# Study Of Prevention of Chemo-Induced Nausea and Vomiting Caused By Moderately Emetogenic Chemotherapy

> **NCT00104403** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 722 (actual)

## Conditions studied

- Nausea and Vomiting, Chemotherapy-Induced
- Chemotherapy-Induced Nausea and Vomiting

## Interventions

- **DRUG:** GW679769
- **DRUG:** Dexamethasone
- **DRUG:** Ondansetron Hydrochloride

## Key facts

- **NCT ID:** NCT00104403
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-12
- **Primary completion:** 2006-01
- **Final completion:** 2006-01
- **Target enrollment:** 722 (ACTUAL)
- **Last updated:** 2015-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00104403

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00104403, "Study Of Prevention of Chemo-Induced Nausea and Vomiting Caused By Moderately Emetogenic Chemotherapy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00104403. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*